Professional
Added to YB: 2024-02-29
Pitch date: 2024-02-28
BAYRY [neutral]
Bayer Aktiengesellschaft
+41.83%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 36.9B
Pitch Price
EUR 27.99
Price Target
N/A
Dividend
0.29%
EV/EBITDA
7.31
P/E
-10.20
EV/Sales
1.47
Sector
Pharmaceuticals
Category
turnaround
Pernas Research Passes on Bayer - $BAYRY
BAYRY: $32B market cap, $7.88 price. 20 years of stagnation due to Monsanto deal, $11B in Roundup lawsuit costs, shares -70%. $10B pharma pipeline undervalued. Crop science profits falling on price normalization. Better entry point likely ahead as litigation concerns linger.
Read full article (1 min)